合成生物学の世界市場レポート 2024

合成生物学の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には21.5%の年間複合成長率（CAGR）で458億3,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、政府の取り組みの高まり、代替燃料への需要の高まり、遺伝子組み換え作物への関心の高まり、非公開会社への投資の拡大によるものと考えられます。予測期間中に予想される主な動向には、戦略的提携とパートナーシップ、ヌクレオチド合成と配列決定における自動化の統合、遺伝子編集への一層の注力、継続的な製品革新、無細胞技術の採用増加、環境に優しい新しい技術の開発、バイオ燃料の生産プロセスなどが含まれます。

DNAシーケンスは、合成生物学をさまざまな方法で進化させる上で重要な役割を果たします。その重要性は、合成生物学内での広範なアプリケーションによって強調されます。費用対効果の高いDNAシーケンス技術の利用が、合成生物学アプリケーションに合わせた製品の生産を刺激します。この技術により、研究者は遺伝子内のDNA配列を解読できるようになり、包括的なゲノムリポジトリの作成が容易になります。これらのリポジトリは、タンパク質発現、指向性進化、代謝工学などの合成生物学アプリケーションを実装するための基盤として機能します。特に、ヒトゲノム調査は、配列決定されたゲノムあたりのコストが過去17年間で30億米ドルから約3億米ドルに減少し、今後5年間でさらに10分の1に減少すると予測されていると報告しています。

個別化医療に対する需要の高まりにより、合成生物学市場の成長が促進される見込みです。個別化医療は精密医療とも呼ばれ、個々の患者の特定の特性に合わせた医療処置のカテゴリーを構成します。 合成生物学は個別化医療において重要な役割を果たし、個人の個別の遺伝的および分子的プロファイルに基づいて治療と介入をカスタマイズするための強力なツールと技術を提供します。たとえば、2023年に個別化医療連合は、2022年にFDAが新薬の34%について個別化医療を承認したと報告しました。過去8年間で、これらの医薬品は新薬の少なくとも25%で承認されました。したがって、個別化医療に対する需要の高まりが、合成生物学市場の成長の主要な原動力として浮上しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の合成生物学市場、技術別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• ヌクレオチドの合成と配列決定
• バイオインフォマティクス
• マイクロ流体工学
• 遺伝子工学
• 世界の合成生物学市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• オリゴヌクレオチド
• 酵素
• クローン作成キットとアセンブリキット
• ゼノ核酸（XNA）
• シャーシ本体
• 世界の合成生物学市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 医薬品と診断薬
• 化学薬品
• バイオ燃料
• バイオプラスチック
• その他の用途

第7章 地域および国の分析

• 世界の合成生物学市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の合成生物学市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 合成生物学市場の競合情勢
• 合成生物学市場の企業プロファイル
  • Thermo Fisher Scientific Inc
  • Danaher Corporation
  • Eurofins Scientific
  • Merck KGaA
  • Novozymes A/S

第31章 その他の大手および革新的な企業

• Agilent Technologies
• New England Biolabs Inc
• Precigen Inc
• Amyris, Inc
• Genscript Biotech Corporation
• Codex Genetics
• Cathay Biotech
• Bota Biosciences
• Bluepha
• Spiber
• OriCiro Genomics Inc
• Provectus Algae
• Puraffinity
• Royal DSM NV
• Colorifix

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Synthetic biology is a branch of biological science that applies engineering principles to redesign organisms, endowing them with new functionalities. It can be viewed as the culmination or the deliberate, prescriptive stage of biology.

The primary product categories within synthetic biology include oligonucleotides, enzymes, cloning and assembly kits, xeno-nucleic acids (XNA), and chassis organisms. Oligonucleotides refer to small single-stranded DNA segments that, upon internalization by the cell, can selectively suppress the expression of a single protein. Various technologies, such as nucleotide synthesis and sequencing, bioinformatics, microfluidics, and genetic engineering, are employed in applications spanning pharmaceuticals and diagnostics, chemicals, biofuels, bioplastics, and other related fields.

The synthetic biology market research report is one of a series of new reports from The Business Research Company that provides synthetic biology market statistics, including synthetic biology industry global market size, regional shares, competitors with a synthetic biology market share, detailed synthetic biology market segments, market trends and opportunities, and any further data you may need to thrive in the synthetic biology industry. This synthetic biology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The synthetic biology market size has grown exponentially in recent years. It will grow from $16.59 billion in 2023 to $21.02 billion in 2024 at a compound annual growth rate (CAGR) of 26.7%. The expansion observed in the historical period can be credited to the growth of healthcare and life science facilities, augmented investment in drug development, widespread application across various end-user industries, cost-effectiveness of DNA sequencing and synthesizing, and an upsurge in funding.

The synthetic biology market size is expected to see exponential growth in the next few years. It will grow to $45.83 billion in 2028 at a compound annual growth rate (CAGR) of 21.5%. The anticipated growth in the forecast period can be ascribed to the rise in government initiatives, a growing demand for fuel alternatives, increased interest in genetically modified crops, and escalating investments in private companies. Key trends expected during the forecast period encompass strategic collaborations and partnerships, the integration of automation in nucleotide synthesis and sequencing, a heightened focus on gene editing, continuous product innovation, an increasing adoption of cell-free technology, and the development of new environmentally friendly processes for biofuel production.

DNA sequencing plays a crucial role in advancing synthetic biology in various ways. Its significance is underscored by its widespread applications within synthetic biology, where the availability of cost-effective DNA sequencing techniques stimulates the production of products aligned with synthetic biology applications. The technique enables researchers to decipher DNA sequences in genes, facilitating the creation of comprehensive genome repositories. These repositories serve as the foundation for implementing synthetic biology applications, including protein expression, directed evolution, and metabolic engineering. Notably, the Human Genome Research Institute reported that the cost per sequenced genome decreased from $3 billion to around $300 million over the past 17 years, with a projected further reduction by 10 times over the next five years.

The rising demand for personalized medicine is poised to drive the growth of the synthetic biology market. Personalized medicine, also referred to as precision medicine, constitutes a category of medical treatments tailored to the specific characteristics of individual patients. Synthetic biology plays a crucial role in personalized medicine, offering potent tools and techniques to customize medical treatments and interventions based on an individual's distinct genetic and molecular profile. For instance, in 2023, the Personalized Medicine Coalition reported that in 2022, the FDA approved personalized medicines for 34% of new drugs. Over the previous eight years, these medicines were approved for at least 25% of new drugs. Thus, the escalating demand for personalized medicine emerges as a key driver for the growth of the synthetic biology market.

Recent technological advancements in DNA sequencing have empowered researchers to utilize DNA as a means to store non-genetic information. Given the escalating demand for data storage, DNA data storage presents a viable solution, with a single DNA strand capable of storing approximately 455 Exabytes of data (equivalent to 455 billion gigabytes). Consequently, this concept has attracted significant investments from market entities. Binary data, represented in 0s and 1s, is translated into DNA strings comprising four distinct base units-A, G, C, T (Adenine, Guanine, Cytosine, and Thymine). Notably, information encoded in DNA can endure for thousands of years, a remarkable contrast to traditional hard drives where data corruption or damage may occur within 30 years. For instance, a Nature Publishing Group journal reported that Microsoft and University of Washington researchers successfully stored over 200 megabytes of data, equivalent to 35 distinct digital files, in DNA. There are plans for increased investment to enhance this technology further.

Major companies active in the synthetic biology market are making strategic investments to drive innovation, research, and development in DNA synthesis technology. Investments in synthetic biology encompass financial backing and funding for companies and projects within this domain. In January 2022, Ribbon Biolabs GmbH, an Austrian biotechnology company, secured $19.12 million (approximately 18 million euros) in a series A funding round. This funding facilitated the establishment of commercial-scale manufacturing facilities and advancements in DNA synthesis technology in the United States. The potential outcomes include the development of new drugs, gene editing therapies, and personalized medicines, thereby improving the lives of numerous patients.

In July 2022, Ginkgo Bioworks, a US-based biotech company, completed the acquisition of Zymergen for $300 million. This strategic move is aimed at fortifying Ginkgo's platform, expanding its product portfolio, broadening its customer base, and achieving cost efficiencies. Zymergen, the acquired company, employs synthetic biology to create and manufacture various products, including materials, microbes, and therapeutics.

Major companies operating in the synthetic biology market report are Thermo Fisher Scientific Inc., Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S, Agilent Technologies, New England Biolabs Inc., Precigen Inc., Amyris, Inc., Genscript Biotech Corporation, Codex Genetics, Cathay Biotech, Bota Biosciences, Bluepha, Spiber, OriCiro Genomics Inc., Provectus Algae, Puraffinity, Royal DSM NV, Colorifix, Phytoform Labs, Desktop Genetics, NanoSyrinx, Pulmobiotics S.L, EnginZyme, Chain Biotech, Nuclera Nucleics, Biosynthetics GmbH, Entelechon GmbH, Sloning BioTechnology GmbH, Prokarium Ltd., Synbio, Captor Therapeutics, Gero.ai, ARNA Genomics, Solvo Omixon, Soft flow, Algenol, Genomatica, Integrated DNA Technologies, Sana Biotechnology, Impossible Foods, Apeel Sciences, Twist Bioscience, Synlogic, Zymergen Inc., Ginkgo Bioworks, Codexis, Arzeda Corporation, Synthetic Genomics, Conagen, Dupont, Oxitec Ltd., Sentebiolab, GEEN Biotechnology Inc., Genbiotek Biosistem Laboratory Ltd

North America was the largest region in the synthetic biology market in 2023. Western Europe was the second largest region in the global synthetic biology market share. The regions covered in the synthetic biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the synthetic biology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The synthetic biology market includes revenue earned by synthetic compound, technology and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Synthetic Biology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on synthetic biology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for synthetic biology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The synthetic biology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Technology: Nucleotide Synthesis And Sequencing; Bioinformatics; Microfluidics; Genetic Engineering
• 3) By Product Type: Oligonucleotides; Enzymes; Cloning And Assembly Kits; Xeno-Nucleic Acids (XNA); Chassis Organism
• 2) By Application: Pharmaceuticals And Diagnostics; Chemicals; Biofuels; Bioplastics; Other Application
• Companies Mentioned: Thermo Fisher Scientific Inc; Danaher Corporation; Eurofins Scientific; Merck KGaA; Novozymes A/S
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Synthetic Biology Market Characteristics

3. Synthetic Biology Market Trends And Strategies

4. Synthetic Biology Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Synthetic Biology Market Size and Growth

• 5.1. Global Synthetic Biology Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Synthetic Biology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Synthetic Biology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Synthetic Biology Market Segmentation

• 6.1. Global Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Nucleotide Synthesis And Sequencing
• Bioinformatics
• Microfluidics
• Genetic Engineering
• 6.2. Global Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oligonucleotides
• Enzymes
• Cloning and Assembly Kits
• Xeno-nucleic Acids (XNA)
• Chassis Organism
• 6.3. Global Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceuticals And Diagnostics
• Chemicals
• Biofuels
• Bioplastics
• Other Applications

7. Synthetic Biology Market Regional And Country Analysis

• 7.1. Global Synthetic Biology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Synthetic Biology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Synthetic Biology Market

• 8.1. Asia-Pacific Synthetic Biology Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Synthetic Biology Market

• 9.1. China Synthetic Biology Market Overview
• 9.2. China Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Synthetic Biology Market

• 10.1. India Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Synthetic Biology Market

• 11.1. Japan Synthetic Biology Market Overview
• 11.2. Japan Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Synthetic Biology Market

• 12.1. Australia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Synthetic Biology Market

• 13.1. Indonesia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Synthetic Biology Market

• 14.1. South Korea Synthetic Biology Market Overview
• 14.2. South Korea Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Synthetic Biology Market

• 15.1. Western Europe Synthetic Biology Market Overview
• 15.2. Western Europe Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Synthetic Biology Market

• 16.1. UK Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Synthetic Biology Market

• 17.1. Germany Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Synthetic Biology Market

• 18.1. France Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Synthetic Biology Market

• 19.1. Italy Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Synthetic Biology Market

• 20.1. Spain Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Synthetic Biology Market

• 21.1. Eastern Europe Synthetic Biology Market Overview
• 21.2. Eastern Europe Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Synthetic Biology Market

• 22.1. Russia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Synthetic Biology Market

• 23.1. North America Synthetic Biology Market Overview
• 23.2. North America Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Synthetic Biology Market

• 24.1. USA Synthetic Biology Market Overview
• 24.2. USA Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Synthetic Biology Market

• 25.1. Canada Synthetic Biology Market Overview
• 25.2. Canada Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Synthetic Biology Market

• 26.1. South America Synthetic Biology Market Overview
• 26.2. South America Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Synthetic Biology Market

• 27.1. Brazil Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Synthetic Biology Market

• 28.1. Middle East Synthetic Biology Market Overview
• 28.2. Middle East Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Synthetic Biology Market

• 29.1. Africa Synthetic Biology Market Overview
• 29.2. Africa Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Synthetic Biology Market Competitive Landscape And Company Profiles

• 30.1. Synthetic Biology Market Competitive Landscape
• 30.2. Synthetic Biology Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Danaher Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Eurofins Scientific
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck KGaA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novozymes A/S
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Synthetic Biology Market Other Major And Innovative Companies

• 31.1. Agilent Technologies
• 31.2. New England Biolabs Inc
• 31.3. Precigen Inc
• 31.4. Amyris, Inc
• 31.5. Genscript Biotech Corporation
• 31.6. Codex Genetics
• 31.7. Cathay Biotech
• 31.8. Bota Biosciences
• 31.9. Bluepha
• 31.10. Spiber
• 31.11. OriCiro Genomics Inc
• 31.12. Provectus Algae
• 31.13. Puraffinity
• 31.14. Royal DSM NV
• 31.15. Colorifix

32. Global Synthetic Biology Market Competitive Benchmarking

33. Global Synthetic Biology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Synthetic Biology Market

35. Synthetic Biology Market Future Outlook and Potential Analysis

• 35.1 Synthetic Biology Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Synthetic Biology Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Synthetic Biology Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer